Within this project, we aimed to use a semi to high-throughput approach to evaluate various protein-fat matrix formulations (including processing conditions) and screen a selection of microorganisms and their impact on texture and taste formation (during ageing).
In this blog, Ethan Almond reflects on the inaugral BioSolutions UK conference, which brought together over 200 innovators, policymakers and industry leaders alongside an additional 29 investors.
The UK BioIndustry Association (BIA) is the UK’s trade association for innovative life sciences and the leading UK-wide forum for expert communities and high quality peer-to-peer networking in the sector.
The UK’s biosolutions sector has established itself as a billion-pound frontier industry, with companies raising £1.46 billion in equity investment since 2018.
With £1.46 billion raised since 2018 and a record recovery in 2025, the UK biosolutions sector is moving from lab-based experiments to industrial-scale impact. Explore the data behind the UK's next industrial revolution.
The European Food Safety Authority has launched a call for SMEs and first-time applicants interested in receiving EFSA’s advice on the application requirements for food additives authorisation in the EU market.
In this guest blog, Paul Jeffrey, Director of the GFIL/Cranfield Technology Accelerator at Cranfield Water Science Institute, explains how engineering biology solutions for environmental applications face unclear and complex regulatory pathways.
Fermtech has raised £2.5m to scale Koji Cocoa™, a fermentation-based cocoa ingredient made from cocoa shells that delivers 25–33% cost savings and up to 98% lower carbon emissions.
This guest blog from Cam Watson, biosolutions startup advisor, draws on a broader analysis of Japan’s biosolutions ecosystem, examining company formation, corporate engagement, manufacturing capacity and growth-stage funding dynamics.
I’m pleased to share that we are part of a new Government and industry joint taskforce to drive innovation in the UK’s commercial environment for medicines, announced last week as part of government ambitions for the Life Sciences Strategy.
